Exendin-4 (Exe4), a synthetic peptide that potently activates GLP-1, is known for its effective weight loss properties 17,18,19
Interestingly, in a murine model of colon cancer, Eissa et al.., 2019 found that S
Market Health Understanding the tension between investment, access, and market demand Venture capital trends Investigating development and manufacturing supply chains Interacting with regulatory bodies from legislators to state licensing boards Patient Safety Discussing the different sources of GLP1s and their implications on consumer choice, market health, and patient safety Traditional prescriptions Telehealth providers Peptide sellers Other gray market sources Describing the different online consumer marketing and prescribing workflows with Telehealth providers and what factors relate to patient safety concerns Assessing current guidelines for patient follow-up and prescription timelines Telehealth vs
[DOI] [PubMed] [Google Scholar] King D, Yeomanson D, Bryant HE